Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.
Open Access
- 26 July 1988
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 26 (1) , 31-39
- https://doi.org/10.1111/j.1365-2125.1988.tb03360.x
Abstract
1. The effect of dose (100 mg, 250 mg, 500 mg, 750 mg and 1000 mg) on the glucuronidation and sulphation of diflunisal was studied in six healthy volunteers. 2. Total urinary recovery ranged from 78.9 +/- 11.9% to 91.5 +/- 18.7% of the administered dose. Urinary recovery (normalized for total urinary recovery) of diflunisal sulphate (DS) significantly increased with dose from 9.3 +/- 3.7% to 18.1 +/- 4.8%. 3. Normalized urinary recovery for diflunisal phenolic glucuronide (DPG) was unaffected by dose (range: 30.6 +/- 3.8% to 40.6 +/- 6.6%). Normalized urinary recovery for the acyl glucuronide (DAG) significantly decreased from 52.3 +/- 4.6% to 40.2 +/- 3.4% as the dose increased. 4. Total plasma clearance of diflunisal significantly decreased from 14.4 +/- 1.4 ml min-1 to 8.7 +/- 1.4 ml min-1 as the dose increased from 100 mg to 750 mg. A further increase in dose to 1000 mg resulted in an unexplained increase in total plasma clearance to 10.3 +/- 1.8 ml min-1. 5. Dose-dependent plasma clearance of diflunisal was caused mainly by saturation of the formation of DAG, whereas the formation of DS and DPG were relatively unaffected by dose.This publication has 23 references indexed in Scilit:
- Assay methodology for quantification of the ester and ether glucuronide conjugates of diflunisal in human urineJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Properties of Acyl Glucuronides: Implications for Studies of the Pharmacokinetics and Metabolism of Acidic DrugsDrug Metabolism Reviews, 1984
- High-Performance Liquid Chromatographic Analysis of Diflunisal in Plasma and Urine: Application to Pharmacokinetic Studies in Two Normal VolunteersJournal of Pharmaceutical Sciences, 1983
- Pharmacokinetic Consequences and Toxicologic Implications of Endogenous Cosubstrate DepletionDrug Metabolism Reviews, 1982
- Drug metabolite kineticsPharmacology & Therapeutics, 1981
- Negligible excretion of unchanged ketoprofen, naproxen, and probenecid in urineJournal of Pharmaceutical Sciences, 1980
- DiflunisalDrugs, 1980
- Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesicBiochemical Pharmacology, 1980
- Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.British Journal of Clinical Pharmacology, 1979
- Diflunisal: a review of pharmacokinetic and pharmacodynamic properties, drug interactions, and special tolerability studies in humans.British Journal of Clinical Pharmacology, 1977